Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty
- PMID: 21691451
- PMCID: PMC3117584
- DOI: 10.1177/1941738110386705
Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty
Abstract
CONTEXT: The indications for use of growth hormone (GH) have broadened with the availability of unlimited recombinant human growth hormone (rhGH). The FDA's approval for use of growth hormone in GH-sufficient patients with idiopathic short stature includes some children with constitutional delay of growth and puberty (CGD), a normal growth pattern variation which includes delayed puberty and prolonged linear growth, usually leading to normal adult height. Use of rhGH to increase growth in short-statured children with CGD has been challenged for its modest efficacy in increasing ultimate height, high cost, limited evidence for psychosocial benefit, and some unresolved concerns about long-term post-treatment safety. An additional controversy for the young athlete with CGD is the concern for fairness in competition. EVIDENCE ACQUISITION: Data sources were limited to peer-reviewed publications. RESULTS: RhGH is a safe and effective therapy for increasing growth rate in very short children with CGD, but does not markedly increase ultimate stature nor confer a clear benefit in athletic performance. (SORT A) CONCLUSIONS: Prescribing physicians should use rhGH treatment responsibly to bring children disabled by short stature just into the "normal" range. (SORT C).
Conflict of interest statement
No potential conflict of interest declared.
Figures


Similar articles
-
Should Skeletal Maturation Be Manipulated for Extra Height Gain?Front Endocrinol (Lausanne). 2021 Dec 16;12:812196. doi: 10.3389/fendo.2021.812196. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975773 Free PMC article. Review.
-
Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.Acta Biomed. 2019 Sep 23;90(8-S):43-51. doi: 10.23750/abm.v90i8-S.8506. Acta Biomed. 2019. PMID: 31544806 Free PMC article.
-
Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.Clin Endocrinol (Oxf). 1995 Apr;42(4):365-72. doi: 10.1111/j.1365-2265.1995.tb02644.x. Clin Endocrinol (Oxf). 1995. PMID: 7750190 Clinical Trial.
-
The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.Horm Res. 1998;49 Suppl 2:41-57. doi: 10.1159/000053087. Horm Res. 1998. PMID: 9730672 Review.
-
Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.Curr Pharm Biotechnol. 2000 Jul;1(1):33-46. doi: 10.2174/1389201003378997. Curr Pharm Biotechnol. 2000. PMID: 11467359 Review.
Cited by
-
Evaluation of near final height in boys with constitutional delay in growth and puberty.Endocr Connect. 2018 Mar;7(3):456-459. doi: 10.1530/EC-18-0043. Epub 2018 Feb 19. Endocr Connect. 2018. PMID: 29459422 Free PMC article.
References
-
- Allen DB, Fost N. hGH for short stature: ethical issues raised by expanded access. J Pediatr. 2004;144(5):648-652 - PubMed
-
- Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab. 2010;95(1):167-177 - PubMed
-
- Berggren A, Ehrnborg C, Rosen T, Ellegard L, Bengtsson BA, Caidahl K. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes. J Clin Endocrinol Metab. 2005;90(6):3268-3273 - PubMed
-
- Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev. 2007;3:CD004440 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources